Giuseppe Fornarini
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 186 publications
Integrating PSMA PET into urological practice: insights from a multidisciplinary Italian survey.
Journal: Minerva urology and nephrology
Published: June 19, 2026
Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study).
Journal: Minerva urology and nephrology
Published: April 23, 2026
Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069].
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study.
Journal: Frontiers in immunology
Published: February 26, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study.
Journal: NPJ precision oncology
Published: January 18, 2026
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study.
Journal: Clinical genitourinary cancer
Published: January 14, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy Combinations.
Journal: The oncologist
Published: December 16, 2025
Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.
Journal: The oncologist
Published: December 16, 2025
Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.
Journal: Frontiers in oncology
Published: November 25, 2025
Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 16, 2025
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study.
Journal: Cancer immunology, immunotherapy : CII
Published: October 24, 2025
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Journal: Cancer immunology, immunotherapy : CII
Published: October 14, 2025
Last Updated: 09/26/2026